Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors

(Bentham Science Publishers) Immune checkpoint inhibitors are a new promising class of antitumor drugs that have been associated with a number of immune-related Adverse Events (AEs), including musculoskeletal and rheumatic disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news